Canadian Access to Hormonal Contraceptive Drug Choices

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 5, 2004, Pages 489-499

  Azzarello, Dianne ^a   Collins, John ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Canada; Contraceptive agents; Contraceptives, oral, hormonal; Drug approval; Drugs, investigational

Indexed keywords

CONTRACEPTIVE AGENT; NEW DRUG; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANADA; DRUG APPROVAL; DRUG LEGISLATION; FEMALE; HUMAN; SAFETY;

CANADA; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; DRUG APPROVAL; DRUGS, INVESTIGATIONAL; FEMALE; HUMANS; LEGISLATION, DRUG; SAFETY;

EID: 3242735950     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30660-0     Document Type: Article

References (20)

1. Draft guidance for industry: clinical development of steroidal contraceptives used by women 2001, Health Products and Food Branch guidance document. http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/index_drugs_information_guidelines_e.html#oc.
2. Guidance for industry: clinical development of steroidal contraceptives used by women; October 29, 2002 2002, Health Products Food Branch guidance document. http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/index_drugs_information_guidelines_e.html#oc.
3. Australian prescription products guide (APP). Available at . Accessed May 13, 2002.
4. British national formulary, No. 43, March 2002 on-line edition. Available at . Accessed May 13, 2002.
5. Conference Canadian Consensus Hormonal contraception. J Soc Obstet Gynaecol Can 1998, 20(6):581-589.
6. Food US, Administration Drug Center for Drug Evaluation and Research 2002, http://www.fda.gov/cder.
7. Compendium of pharmaceuticals and specialties 2002, Canadian Pharmacists Association, Canadian Pharmacists Association, Ottawa.
8. site Therapeutic Products Directorate Web Drug product database. Notices of compliance 2002, http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/index-drugs_dpd_e.html.
9. Burnham T Drug facts and comparisons 2001, Wolters Kluwer Health, St. Louis (MO).
10. Hatcher RA, Nelson AL, Zieman M, Darney PD, Creinin MD, Stosur HR A pocket guide to managing contraception 200l-2002 2001, Bridging the Gap Foundation, Tiger (GA).
11. Directory of hormonal contraceptives 2002, International Planned Parenthood. http://http://contraceptive.ippf.org/Trusted/Defeult.asp.
12. Muller NF, Dessing RP European drug index 1997, Deutscher Apotheker Verlag, Stuttgart.
13. Martindales Parfitt K The complete drug reference 1999, Pharmaceutical Press, London (UK).
14. Sifton DW Physicians desk reference. 55th edition 2001, Medical Economics Company, Montvale (NJ).
15. health Women's NuvaRing, the first contraceptive vaginal ring. Pharmacist's Letter 2001, 17(11):62.
16. Index nominum 2000 international drug directory 2000, Swiss Pharmaceutical Society, Medpharm Scientific Publishers, Bern-Liebefeld.
17. USP-DI Drug information for the health care professional 2000, Micromedex, Engelwood (CO).
18. Schwartz M Annual drug submission performance report. Part 1: Bureau of Pharmaceutical Assessment (BRA) 2002, http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/index_drugs_reports_annual_e.html.
19. Rawson NSB, Kaitin KI New drug approval times and "therapeutic potential" in Canada, Australia, Sweden and the United States during the period 1992 to 1998. Can J Clin Pharmacol 2000, 7(2):97-101.
20. Metters J Medicines Commission advice on third generation oral contraceptives and risk of venous thromboembolism 2003, http://www.mca.gov.uk.